Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A
about
Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisFrom the stomach to other organs: Helicobacter pylori and the liverMetabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and HepatokinesPathophysiology of Non Alcoholic Fatty Liver DiseaseArterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alphaAmelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null miceEnhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG)Fetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cellsUrinary biomarkers as a diagnostic tool for acute kidney injury.Molecular epidemiological study on pre-X region of hepatitis B virus and identification of hepatocyte proteins interacting with whole-X protein by yeast two-hybridFetuin-A induces cytokine expression and suppresses adiponectin production.From the bench to the clinic and back again: translational biomarker discovery using in silico mining of pharmacogenomic data.Investigation of an albumin-enriched fraction of human serum and its albuminome.Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria.Identification of coexpressed gene clusters in a comparative analysis of transcriptome and proteome in mouse tissues.Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adultsCirculating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.Intraperitoneal administration of fetuin-A attenuates D-galactosamine/lipopolysaccharide-induced liver failure in mouseAssociation between fetuin-A levels with insulin resistance and carotid intima-media thickness in patients with new-onset type 2 diabetes mellitus.Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation.Biochemistry and clinical role of human cystatin C.Identification of novel tissue-specific genes by analysis of microarray databases: a human and mouse model.Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.Hepatokines as a Link between Obesity and Cardiovascular Diseases.Association of plasma Fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus.The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic miceEffects of lipid composition and solution conditions on the mechanical properties of membrane vesicles.Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression.Matrix γ-carboxyglutamate protein and Fetuin-A, in wet type age-related macular degenerationThe liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology.Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy.Fetuin A concentration in the second trimester amniotic fluid of fetuses with trisomy 21 appears to be lower: phenotypic considerationsFetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studiesSerum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article.Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia.The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies.Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variablesPlasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S.Plasma fetuin-A levels and the risk of type 2 diabetes.
P2860
Q26775340-CB553A97-D238-4772-818A-D804E49DAE59Q26795532-28DC752B-9535-4E8B-87BA-D49231516BD8Q28066564-8D82B4D1-1FCD-427E-B143-0F1515DF41A2Q28070011-7261A129-E10D-4A9F-B294-4B34987059CEQ28511092-6898D8D5-53CE-416C-9520-4B5C555E0338Q28593754-A2FDF93D-BF73-4405-8BEB-6B5832A47E7DQ28594971-16CFA677-AC78-438E-8C91-9C381FB16332Q30429199-19D39BBB-281D-4FD8-924E-8DA2F9116A25Q30450879-302B0F37-614D-4973-A32F-896F7C02A733Q33216835-334C3865-A041-4DC5-B4AA-8C9ECBB2FE36Q33323370-9C058758-B6FA-41E3-87CF-ECBB5368542EQ33579381-5CDDE0D9-BA11-4EF9-9FFF-8AB5660993ACQ33701508-7ACEECEC-B27D-49C3-BEB7-D9EEFAF8F511Q33701562-E81A7412-6BA2-4019-B63E-B3057330A865Q33842906-7F5CF38D-1670-4AFC-97D7-E85B5CDF0385Q33893894-D0817B03-08DA-4E88-9E81-A3060B6E96B1Q33924942-588F84D5-0489-449C-AC31-AAD10F38765FQ33990872-06F8C48E-072E-4C1D-8216-A5520D79DA31Q34265410-FB6AAE7E-E0D6-4223-9D07-508B33084548Q34299733-AF61C5CE-E1A5-48AC-A0AE-9684783EA3D9Q34377103-264D6F69-F4D9-49E3-A5D1-2E9540E65172Q34760518-56E325AB-0B2C-4733-97AD-BDB38A56DD93Q34844992-B2F9E93E-32FC-4F4A-B7D2-688C75BD511AQ35117340-9EB24F3A-067E-4C51-9ED0-EFD3AC2B02DEQ35126823-F421020A-E06E-48F7-94BE-1B2DBDB50354Q35173696-8EA88B51-DB14-4DA3-A673-371D86A246FAQ35196457-28FB3BEB-11D5-4785-BD2F-EF45B32D3DB2Q35547173-DA0EE436-CEEC-4060-B95F-5942F155AA02Q35559202-78EF795A-BF07-4ECC-9524-77C22EEA0AF6Q35691938-1E4A8F91-602D-46D2-85A5-3F3AA32641D5Q35774603-EE3FD6F2-3030-4AE6-9520-94A3E916411AQ35821513-9710D136-10C1-4F63-9D04-729569889568Q35837896-C7EFB9B8-79F3-4C19-B6C6-7313D1DE6CD0Q36173735-E2C5F0A9-DFED-4372-A246-FAE0D814C41AQ36195780-1573D849-FB55-47E5-97ED-E6CE898E7EB8Q36302698-37CDAC7A-75E3-4AD7-8B2F-FF4726361542Q36413070-BDD1845C-5339-4390-A1EF-2F1A46374CB8Q36423049-FAA48FAE-F7D1-46E5-9F65-A6E973739CD3Q36477337-D5C88058-2870-4DD0-BD1A-28F0F50BB296Q36906385-725217A1-BD60-4A78-92C4-013971B204D9
P2860
Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@ast
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@en
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@en-gb
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@nl
type
label
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@ast
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@en
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@en-gb
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@nl
prefLabel
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@ast
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@en
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@en-gb
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@nl
P2093
P2860
P3181
P356
P1433
P1476
Tissue distribution and activi ...... ction of fetuin-B and fetuin-A
@en
P2093
Alexander Heiss
Bernd Denecke
Cora Schäfer
Michael Wöltje
Steffen Gräber
Willi Jahnen-Dechent
P2860
P304
P3181
P356
10.1042/BJ20030676
P407
P577
2003-11-15T00:00:00Z